EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke

Zhixuan Huang, Jian Liu, Hui Li, Hengjun Huang, Yangwen Ai, Dongyue Zhou iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0327133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zhixuan Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academ…. Hauptthemen laut MEDLINE: Network Pharmacology, Indole Alkaloids, Ischemic Stroke, Quinazolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central Public Welfare Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evodia rutaecarpa is a traditional Chinese herbal medicine known for its potential benefits in the treatment of cardiovascular and cerebrovascular diseases. Despite its recognized effects, the effects of Evodia rutaecarpa on ischemic stroke (IS), along with the primary active compounds and precise mechanisms of action, require elucidation.

Methods

Network pharmacology analyses and molecular docking were performed to integrate information related to Evodia rutaecarpa and IS. Cell oxygen–glucose deprivation (OGD) and rat middle cerebral artery occlusion (MCAO) models were established to simulate cerebral ischemic injury. The effects of rutaecarpine on these models were evaluated to assess its effect on IS.

Results

Network pharmacological analysis indicated that rutaecarpine from Evodia rutaecarpa showed therapeutic effects against IS. The mechanism underlying these effects mainly involved the mitogen-activated protein kinase (MAPK), and targets such as matrix metalloproteinase (MMP)-9, caspase 3 and MMP-2 may be activated to exert these effects. In vitro studies showed that rutaecarpine significantly improved the mitochondrial membrane potential of HT22 cells, reduced the production of reactive oxygen species, and reversed OGD-induced cytotoxicity. In the MCAO rat model, pretreatment with rutaecarpine significantly reduced neuronal death, decreased infarct volume, and improved neurological functional deficits. In addition, rutaecarpine alleviated damage to the blood–brain barrier in the brain tissue. These effects may be related to the regulation of the MAPK-mediated MMPs pathway.

Conclusion

This study revealed the neuroprotective effects and molecular mechanisms of rutaecarpine on IS, providing a new theoretical basis for the clinical application of Evodia rutaecarpa .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyIndole AlkaloidsIschemic StrokeQuinazolinesEvodiaNeuroprotective AgentsAnimalsRatsMaleRats, Sprague-DawleyMolecular Docking SimulationMembrane Potential, MitochondrialInfarction, Middle Cerebral ArteryDisease Models, AnimalReactive Oxygen SpeciesMiceGlucoseCell LineDrugs, Chinese HerbalQuinazolinones

Substanzen

rutecarpineIndole AlkaloidsQuinazolinesNeuroprotective AgentsReactive Oxygen SpeciesGlucoseDrugs, Chinese HerbalQuinazolinones

Autor:innen und Institutionen

  • Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, China.
  • Jiangxi Health Industry Institute of Traditional Chinese Medicine, Nanchang, China.
  • Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

ORCID-Profile: Dongyue Zhou

Förderung

  • the Fundamental Research Funds for the Central Public Welfare Research Institutes

Zitieren

APA

Huang, Z., Liu, J., Li, H., Huang, H., Ai, Y., & Zhou, D. (2025). Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke. PLOS One. https://doi.org/10.1371/journal.pone.0327133

Vancouver

Huang Z, Liu J, Li H, Huang H, Ai Y, Zhou D. Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke. PLOS One. 2025. doi:10.1371/journal.pone.0327133

BibTeX
@article{Huang2025,
  author = {Huang, Zhixuan and Liu, Jian and Li, Hui and Huang, Hengjun and Ai, Yangwen and Zhou, Dongyue},
  title = {Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327133}
}
Kostenlos starten →